- Home
- LNTH vs QFIN Comparison
LNTH vs QFIN Comparison
Compare LNTH & QFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- QFIN
- Stock Information
- Founded
- LNTH 1956
- QFIN 2016
- Country
- LNTH United States
- QFIN China
- Employees
- LNTH 808
- QFIN N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- QFIN Finance: Consumer Services
- Sector
- LNTH Health Care
- QFIN Finance
- Exchange
- LNTH Nasdaq
- QFIN Nasdaq
- Market Cap
- LNTH 3.8B
- QFIN 3.4B
- IPO Year
- LNTH 2015
- QFIN 2018
- Fundamental
- Price
- LNTH $56.28
- QFIN $27.02
- Analyst Decision
- LNTH Buy
- QFIN Strong Buy
- Analyst Count
- LNTH 6
- QFIN 2
- Target Price
- LNTH $74.50
- QFIN $45.10
- AVG Volume (30 Days)
- LNTH 1.5M
- QFIN 1.5M
- Earning Date
- LNTH 11-06-2025
- QFIN 11-18-2025
- Dividend Yield
- LNTH N/A
- QFIN 5.63%
- EPS Growth
- LNTH N/A
- QFIN 68.82
- EPS
- LNTH 3.77
- QFIN 7.06
- Revenue
- LNTH $1,520,653,000.00
- QFIN $2,618,582,596.00
- Revenue This Year
- LNTH N/A
- QFIN $17.10
- Revenue Next Year
- LNTH $2.25
- QFIN $6.28
- P/E Ratio
- LNTH $14.86
- QFIN $3.82
- Revenue Growth
- LNTH 5.75
- QFIN 9.77
- 52 Week Low
- LNTH $47.25
- QFIN $24.83
- 52 Week High
- LNTH $118.21
- QFIN $48.94
- Technical
- Relative Strength Index (RSI)
- LNTH 55.37
- QFIN 44.43
- Support Level
- LNTH $56.03
- QFIN $24.83
- Resistance Level
- LNTH $57.94
- QFIN $26.76
- Average True Range (ATR)
- LNTH 1.56
- QFIN 0.94
- MACD
- LNTH 0.39
- QFIN 0.13
- Stochastic Oscillator
- LNTH 79.58
- QFIN 51.41
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About QFIN Qifu Technology Inc.
Qfin Holdings Inc Formerly Qifu Technology Inc is a Credit-Tech platform in China. It provides credit services more accessible and personalized to consumers and SMEs through Credit-Tech services to financial institutions, whereby it deploys its technology solutions to help financial institutions identify the diversified needs of consumers and SMEs, effectively access prospective borrowers that are creditworthy through multi-channels, enhance credit assessment on prospective borrowers, and manage credit risks and improve collection strategies and efficiency, among others.